Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Marsh

Showing results (1-10 of 337) with videos related to

Pageof 34
Sort By:
British Journal of Clinical Pharmacology|May 21, 2003
Management of severe malaria: implications for researchKevin Marsh
International Health|May 15, 2016
Africa in transition: the case of malariaKevin Marsh
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
The cost of future problem drug use associated with young people's behaviors and circumstancesKevin Marsh
Lancet (London, England)|November 2, 2010
Research priorities for malaria eliminationKevin Marsh
Acta Tropica|June 5, 2004
Pathophysiology of severe malaria in childrenKathryn Maitland, Kevin Marsh
Plos One|February 11, 2021
Prioritizing investments in rapid response vaccine technologies for emerging infections: A portfolio decision analysisDimitrios Gouglas, Kevin Marsh
The Patient|May 31, 2021
Evaluating the Consistency of Patient Preference Estimates: Systematic Variation in Survival-Adverse Event Trade-Offs in Patients with Cancer or Cardiovascular DiseaseKevin Marsh, Nicolas Krucien
Trends in Microbiology|February 6, 2002
The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malariaPeter C Bull, Kevin Marsh
Advances in Parasitology|January 11, 2003
The consequences of reducing transmission of Plasmodium falciparum in AfricaRobert W Snow, Kevin Marsh
Lancet (London, England)|December 3, 2013
30 years of science and technology: the example of malariaKevin Marsh, Robert W Snow
Pageof 34

Showing results (1-10 of 337) with videos related to

Sort By:
Pageof 34
British Journal of Clinical Pharmacology|May 21, 2003
Management of severe malaria: implications for researchKevin Marsh
International Health|May 15, 2016
Africa in transition: the case of malariaKevin Marsh
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
The cost of future problem drug use associated with young people's behaviors and circumstancesKevin Marsh
Lancet (London, England)|November 2, 2010
Research priorities for malaria eliminationKevin Marsh
Acta Tropica|June 5, 2004
Pathophysiology of severe malaria in childrenKathryn Maitland, Kevin Marsh
Plos One|February 11, 2021
Prioritizing investments in rapid response vaccine technologies for emerging infections: A portfolio decision analysisDimitrios Gouglas, Kevin Marsh
The Patient|May 31, 2021
Evaluating the Consistency of Patient Preference Estimates: Systematic Variation in Survival-Adverse Event Trade-Offs in Patients with Cancer or Cardiovascular DiseaseKevin Marsh, Nicolas Krucien
Trends in Microbiology|February 6, 2002
The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malariaPeter C Bull, Kevin Marsh
Advances in Parasitology|January 11, 2003
The consequences of reducing transmission of Plasmodium falciparum in AfricaRobert W Snow, Kevin Marsh
Lancet (London, England)|December 3, 2013
30 years of science and technology: the example of malariaKevin Marsh, Robert W Snow
Pageof 34